• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防母婴传播的进展与新挑战

Progress and Emerging Challenges in Preventing Mother-to-Child Transmission.

作者信息

Chersich Matthew F, Gray Glenda E

机构信息

Perinatal HIV Research Unit, University of the Witwaterstrand, Chris Hani Baragwanath Hospital, Old Potch Road, PO Berstham, Soweto 2013, South Africa.

出版信息

Curr Infect Dis Rep. 2005 Sep;7(5):393-400. doi: 10.1007/s11908-005-0014-0.

DOI:10.1007/s11908-005-0014-0
PMID:16107237
Abstract

There is a widening gulf between the effectiveness of interventions for preventing mother-to-child transmission (PMTCT) of HIV in sub-Saharan Africa and other regions of the world. Compared with long-course, triple antiretroviral regimens used in Brazil, Europe, and the United States, most countries in sub-Saharan Africa use a less effective regimen consisting of single-dose nevirapine (NVP). Furthermore, the documentation of unacceptable levels of resistance following this regimen makes it prudent to review current PMTCT strategies. Not only is it necessary to review the use of single-dose NVP for PMTCT, but efforts to minimize breast milk transmission of HIV should be enhanced. This review summarizes the programmatic and evidence-based reasons for adopting a standardized approach to long-course, triple-drug MTCT prophylaxis in sub-Saharan Africa. Antiretroviral treatment programs in resource-constrained settings have achieved similar levels of effectiveness as high-income countries, despite adopting standardized approaches to antiretroviral treatment. Similarly, in resource-constrained settings with adequate infrastructure and programmatic capacity, use of standardized, long-course, triple-drug regimens for MTCT prevention are likely to achieve levels of effectiveness seen in Brazil, Europe, and the United States.

摘要

在撒哈拉以南非洲地区与世界其他地区,预防艾滋病毒母婴传播(PMTCT)干预措施的有效性差距正在扩大。与巴西、欧洲和美国使用的长疗程三联抗逆转录病毒疗法相比,撒哈拉以南非洲的大多数国家使用的是效果较差的单剂量奈韦拉平(NVP)疗法。此外,该疗法出现不可接受的耐药水平的记录表明,有必要对当前的PMTCT策略进行审查。不仅有必要审查单剂量NVP用于PMTCT的情况,还应加强努力以尽量减少艾滋病毒通过母乳传播。本综述总结了在撒哈拉以南非洲采用标准化长疗程三联药物预防母婴传播的方案和循证理由。尽管资源有限地区的抗逆转录病毒治疗方案采用了标准化的抗逆转录病毒治疗方法,但其有效性水平已与高收入国家相当。同样,在具备适当基础设施和方案能力的资源有限地区,使用标准化长疗程三联药物方案预防母婴传播可能会达到巴西、欧洲和美国的有效性水平。

相似文献

1
Progress and Emerging Challenges in Preventing Mother-to-Child Transmission.预防母婴传播的进展与新挑战
Curr Infect Dis Rep. 2005 Sep;7(5):393-400. doi: 10.1007/s11908-005-0014-0.
2
Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.影响撒哈拉以南非洲地区预防母婴传播艾滋病毒的短期抗逆转录病毒药物预防依从性的因素:综述及对未来消除工作的启示
AIDS Care. 2014;26(7):914-26. doi: 10.1080/09540121.2013.869539. Epub 2013 Dec 20.
3
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
4
Tuberculosis结核病
5
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
6
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.西非抗逆转录病毒治疗及预防围产期和产后艾滋病毒传播:一种两级方法的评估
PLoS Med. 2007 Aug;4(8):e257. doi: 10.1371/journal.pmed.0040257.
7
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低人类免疫缺陷病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003510. doi: 10.1002/14651858.CD003510.pub2.
8
Advances in the prevention of mother-to-child transmission of HIV-1 infection in resource-limited settings.资源有限环境下预防HIV-1感染母婴传播的进展。
AIDS Read. 2005 Sep;15(9):479-80, 487-93.
9
Mother-to-child transmission of HIV-1 in sub-Saharan Africa: past, present and future challenges.撒哈拉以南非洲地区 HIV-1 的母婴传播:过去、现在和未来的挑战。
Life Sci. 2011 May 23;88(21-22):917-21. doi: 10.1016/j.lfs.2010.09.031. Epub 2010 Oct 8.
10
Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.在发展中国家,将预防母婴传播艾滋病毒(PMTCT)项目与其他预防艾滋病毒感染及改善艾滋病毒防治效果的卫生服务相结合。
Cochrane Database Syst Rev. 2011 Jun 15(6):CD008741. doi: 10.1002/14651858.CD008741.pub2.

引用本文的文献

1
Antiretroviral interventions for preventing breast milk transmission of HIV.预防母乳传播艾滋病毒的抗逆转录病毒干预措施。
Cochrane Database Syst Rev. 2014 Oct 4;2014(10):CD011323. doi: 10.1002/14651858.CD011323.
2
HIV pathogenesis: dynamics and genetics of viral populations and infected cells.HIV 发病机制:病毒群体和感染细胞的动力学和遗传学。
Cold Spring Harb Perspect Med. 2013 Jan 1;3(1):a012526. doi: 10.1101/cshperspect.a012526.
3
Efavirenz use during pregnancy and for women of child-bearing potential.孕期及有生育潜力女性使用依非韦伦的情况。

本文引用的文献

1
A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.一项关于两种暴露后预防方案以减少未治疗母亲所生婴儿母婴HIV-1传播的随机试验。
AIDS. 2005 Aug 12;19(12):1289-97. doi: 10.1097/01.aids.0000180100.42770.a7.
2
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.敏感性耐药性检测显示,在单剂量奈韦拉平(NVP)给药后,部分妇女和婴儿体内携带K103N奈韦拉平(NVP)耐药突变的HIV-1变异株长期持续存在:HIVNET 012研究。
J Infect Dis. 2005 Jul 1;192(1):24-9. doi: 10.1086/430742. Epub 2005 Jun 1.
3
AIDS Res Ther. 2006 Apr 7;3:11. doi: 10.1186/1742-6405-3-11.
Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.
分娩期单剂量奈韦拉平给药后耐药性HIV-1的出现情况被大大低估了。
J Infect Dis. 2005 Jul 1;192(1):16-23. doi: 10.1086/430741. Epub 2005 Jun 1.
4
Nelfinavir and nevirapine side effects during pregnancy.孕期使用奈非那韦和奈韦拉平的副作用。
AIDS. 2005 May 20;19(8):795-9. doi: 10.1097/01.aids.0000168973.59466.14.
5
Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?对于血清学状态不明的女性,是否应使用奈韦拉平来预防母婴传播的艾滋病毒?
Bull World Health Organ. 2005 Mar;83(3):224-8. Epub 2005 Mar 16.
6
Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.非洲感染艾滋病毒母亲所生感染与未感染婴儿的死亡率:一项汇总分析。
Lancet. 2004;364(9441):1236-43. doi: 10.1016/S0140-6736(04)17140-7.
7
Child mortality and HIV infection in Africa: a review.非洲的儿童死亡率与艾滋病毒感染:综述
AIDS. 2004 Jun;18 Suppl 2:S27-34. doi: 10.1097/00002030-200406002-00004.
8
Low efficacy of nevirapine (HIVNET012) in preventing perinatal HIV-1 transmission in a real-life situation.在实际情况下,奈韦拉平(HIVNET012)预防围产期HIV-1传播的效果不佳。
AIDS. 2004 Sep 3;18(13):1854-6. doi: 10.1097/00002030-200409030-00018.
9
Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.奈韦拉平在八个非洲国家预防母婴传播艾滋病毒的成本效益
AIDS. 2004 Aug 20;18(12):1661-71. doi: 10.1097/01.aids.0000131353.06784.8f.
10
Rapid HIV-1 testing during labor: a multicenter study.分娩期间的快速HIV-1检测:一项多中心研究。
JAMA. 2004 Jul 14;292(2):219-23. doi: 10.1001/jama.292.2.219.